Binge alcohol drinking elicits persistent negative affect in mice

Behavioural Brain Research

Volumn 291, Issue , 2015, Pages 385-398

  Lee, Kaziya M ^a   Coehlo, Michal ^a   McGregor, Hadley A ^a   Waltermire, Ryan S ^a   Szumlinski, Karen K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amygdala; Anxiety; Binge drinking; BNST; Nucleus accumbens

Indexed keywords

ALCOHOL; EARLY GROWTH RESPONSE FACTOR 1; WATER; CENTRAL DEPRESSANT AGENT; SUGAR INTAKE;

ADULT; AFFECT; ALCOHOL WITHDRAWAL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BASOLATERAL AMYGDALA; BEHAVIOR ASSESSMENT; BINGE DRINKING; CELL ACTIVITY; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; DEPRESSION; DRINKING IN THE DARK; ELEVATED PLUS MAZE; EMOTIONALITY; FORCED SWIM TEST; IMMUNOHISTOCHEMISTRY; LIGHT DARK BOX; MALE; MARBLE BURYING TEST; MOUSE; NEGATIVE AFFECT; NONHUMAN; NOVE OBJECT TEST; NUCLEUS ACCUMBENS CORE; NUCLEUS ACCUMBENS SHELL; PRIORITY JOURNAL; PSYCHOLOGIC TEST; STRIA TERMINALIS; SUCROSE PREFERENCE TEST; AMYGDALA; ANHEDONIA; ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; METABOLISM; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGY; RANDOMIZATION; SEPTUM NUCLEUS; SUGAR INTAKE; WITHDRAWAL SYNDROME;

AMYGDALA; ANHEDONIA; ANIMALS; ANXIETY; BINGE DRINKING; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DEPRESSION; DIETARY SUCROSE; DISEASE MODELS, ANIMAL; ETHANOL; MALE; MICE, INBRED C57BL; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; RANDOM ALLOCATION; SEPTAL NUCLEI; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84931262081     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2015.05.055     Document Type: Article

References (91)

1. National Center for Chronic Disease Prevention and Health Promotion Binge drinking: nationwide problem, local solutions. CDC Vital Signs 2012, 1-4.
2. National Institute on Alcohol Abuse and Alcoholism NIAAA council approves definition of binge drinking. NIAAA Newsl. 2004, 3.
3. Bayard M., et al. Alcohol withdrawal syndrome. Am. Fam. Physician 2004, 69(6):1443-1450.
4. Dawson D.A., Grant B.F., Li T.K. Quantifying the risks associated with exceeding recommended drinking limits. Alcohol. Clin. Exp. Res. 2005, 29(5):902-908.
5. Driessen M., et al. The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders. Alcohol Alcohol. 2001, 36(3):249-255.
6. Koob G.F. Neurobiological substrates for the dark side of compulsivity in addiction. Neuropharmacology 2009, 56:18-31.
7. Tabakoff B., Hoffman P.L. Animal models in alcohol research. Alcohol Res. Health 2000, 24(2):77-84.
8. Spanagel R. Recent animal models of alcoholism. Alcohol Res. Health 2000, 24(2):124-131.
9. Egli M. Can experimental paradigms and animal models be used to discover clinically effective medications for alcoholism?. Addict. Biol. 2005, 10(4):309-319.
10. Becker H.C. Animal models of alcohol withdrawal. Alcohol Res. Health 2000, 24(2):105-113.
11. Freund G. Induction of physical dependence on alcohol in rodents. Adv. Exp. Med. Biol. 1975, 56:311-325.
12. Rhodes J.S., et al. Evaluation of a simple model of ethanol drinking to intoxication in C57BL/6J mice. Physiol. Behav. 2005, 84(1):53-63.
13. Alheid G.F. Extended amygdala and basal forebrain. Ann. N.Y. Acad. Sci. 2003, 985:185-205.
14. Koob G.F., Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001, 24(2):97-129.
15. Cozzoli D.K., et al. Nucleus accumbens mGluR5-associated signaling regulates binge alcohol drinking under drinking-in-the-dark procedures. Alcohol. Clin. Exp. Res. 2012, 36(9):1623-1633.
16. Cozzoli D.K., et al. Binge alcohol drinking by mice requires intact group1 metabotropic glutamate receptor signaling within the central nucleus of the amygdale. Neuropsychopharmacology 2014, 39(2):435-444.
17. McBride W.J., et al. Changes in gene expression in regions of the extended amygdala of alcohol-preferring rats after binge-like alcohol drinking. Alcohol 2010, 44(2):171-183.
18. Freeman K., et al. Coordinated dynamic gene expression changes in the central nucleus of the amygdala during alcohol withdrawal. Alcohol. Clin. Exp. Res. 2013, 37:E88-E100.
19. Ward R.J., Lallemand F., de Witte P. Biochemical and neurotransmitter changes implicated in alcohol-induced brain damage in chronic or 'binge drinking' alcohol abuse. Alcohol Alcohol. 2009, 44(2):128-135.
20. Kaczmarek L., Robertson H.J. Immediate Early Genes and Inducible Transcription Factors in Mapping of the Central Nervous System Function and Dysfunction 2002, xix. Elsevier, Amsterdam Oxford, 370 p.
21. Crabbe J.C., et al. A line of mice selected for high blood ethanol concentrations shows drinking in the dark to intoxication. Biol. Psychiatry 2009, 65(8):662-670.
22. Rhodes J.S., et al. Mouse inbred strain differences in ethanol drinking to intoxication. Genes Brain Behav. 2007, 6(1):1-18.
23. Cozzoli D.K., et al. Binge drinking upregulates accumbens mGluR5-Homer2-PI3K signaling: functional implications for alcoholism. J. Neurosci. 2009, 29(27):8655-8668.
24. Katz R.J. Animal model of depression: pharmacological sensitivity of a hedonic deficit. Pharmacol. Biochem. Behav. 1982, 16(6):965-968.
25. Crawley J.N. Exploratory behavior models of anxiety in mice. Neurosci. Biobehav. Rev. 1985, 9(1):37-44.
26. Bourin M., Hascoet M. The mouse light/dark box test. Eur. J. Pharmacol. 2003, 463(1-3):55-65.
27. Dulawa S.C., et al. Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. J. Neurosci. 1999, 19(21):9550-9556.
28. Misslin R., Ropartz P. Responses in mice to a novel object. Behaviour 1981, 78:169-177.
29. Porsolt R.D., Bertin Jalfre A.M. Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 1977, 229(2):327-336.
30. Karl T., Pabst R., von Horsten S. Behavioral phenotyping of mice in pharmacological and toxicological research. Exp. Toxicol. Pathol. 2003, 55(1):69-83.
31. Walf A.A., Frye C.A. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat. Protoc. 2007, 2(2):322-328.
32. Njung'e K., Handley S.L. Evaluation of marble-burying behavior as a model of anxiety. Pharmacol. Biochem. Behav. 1991, 38(1):63-67.
33. Paxinos G., Franklin K. The Mouse Brain in Stereotaxic Coordinates 2004, Elsevier Academic Press, San Diego, CA. 2nd ed.
34. Herdegen T., Leah J.D. Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res. Rev. 1998, 28(3):370-490.
35. Su Z., et al. Prior extended daily access to cocaine elevates the reward threshold in a conditioned place preference test. Addict. Biol. 2013.
36. Schuckit M.A., Hesselbrock V. Alcohol dependence and anxiety disorders: what is the relationship?. Am. J. Psychiatry 1994, 151(12):1723-1734.
37. Kushner M.G., Abrams Borchardt K.C. The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings. Clin. Psychol. Rev. 2000, 20(2):149-171.
38. Hasin D.S., et al. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch. Gen. Psychiatry 2007, 64(7):830-842.
39. Substance Abuse and Mental Health Services Administration (SAMHSA), National Survey on Drug Use and Health (NSDUH). 2012: Available at: - Tab5.8A. http://www.samhsa.gov/data/NSDUH/2012SummNatFindDetTable/DetTabs/NSDUH-DetTabsSect5peTabs1to56-2012htm.
40. Knapp D.J., Saiers J.A., Pohorecky L.A. Observations of novel behaviors as indices of ethanol withdrawal-induced anxiety. Alcohol Alcohol. 1993, 2:489-493.
41. Rasmussen D.D., et al. Chronic daily ethanol and withdrawal: 2. Behavioral changes during prolonged abstinence. Alcohol. Clin. Exp. Res. 2001, 25(7):999-1005.
42. Hilakivi L.A., Ota M., Lister R.G. Effect of isolation on brain monoamines and the behavior of mice in tests of exploration, locomotion, anxiety and behavioral 'despair'. Pharmacol. Biochem. Behav. 1989, 33(2):371-374.
43. Wright I.K., Upton Marsden N.C.A. Resocialisation of isolation-reared rats does not alter their anxiogenic profile on the elevated X-maze model of anxiety. Physiol. Behav. 1991, 50(6):1129-1132.
44. Kliethermes C.L. Anxiety-like behaviors following chronic ethanol exposure. Neurosci. Biobehav. Rev. 2005, 28(8):837-850.
45. Saitz R., O'Malley S.S. Pharmacotherapies for alcohol abuse. Withdrawal and treatment. Med. Clin. North Am. 1997, 81(4):881-907.
46. Tasman A., et al. Psychiatry 2015, 2 Volume Set. John Wiley & Sons, Hoboken, NJ, p. 1076-1080. Edition 4.
47. Sobin C., Sackeim H.A. Psychomotor symptoms of depression. Am. J. Psychiatry 1997, 154(1):4-17.
48. Porsolt R.D., et al. Rodent models of depression: forced swimming and tail suspension behavioral despair tests in rats and mice. Curr. Protoc. Neurosci. A 2001, Chapter 8: p. Unit 8 10A.
49. Depablo J.M., et al. Learned immobility explains the behavior of rats in the forced swimming test. Physiol. Behav. 1989, 46(2):229-237.
50. West A.P. Neurobehavioral studies of forced swimming: the role of learning and memory in the forced swim test. Prog. Neuropsychopharmacol. Biol. Psychiatry 1990, 14(6):863-877.
51. Polani P.E. Attacks of anxiety, panic and frenzy, and their related depression: a hypothesis. Med. Hypotheses 2004, 63(1):124-127.
52. Foa E.B., Zinbarg R., Rothbaum B.O. Uncontrollability and unpredictability in post-traumatic stress disorder: an animal model. Psychol. Bull. 1992, 112(2):218-238.
53. Blanchard D.C., Griebel G., Blanchard R.J. Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic. Neurosci. Biobehav. Rev. 2001, 25(3):205-218.
54. Gosnell B.A., Krahn D.D. The relationship between saccharin and alcohol intake in rats. Alcohol 1992, 9(3):203-206.
55. Stewart R.B., et al. Consumption of sweet, salty, sour, and bitter solutions by selectively bred alcohol-preferring and alcohol-nonpreferring lines of rats. Alcohol. Clin. Exp. Res. 1994, 18(2):375-381.
56. Kampov-Polevoy A., Garbutt J.C., Janowsky D. Evidence of preference for a high-concentration sucrose solution in alcoholic men. Am. J. Psychiatry 1997, 154(2):269-270.
57. Kranzler H.R., Sandstrom K.A., Van Kirk J. Sweet taste preference as a risk factor for alcohol dependence. Am. J. Psychiatry 2001, 158(5):813-815.
58. Lowery-Gionta E.G., et al. Corticotropin releasing factor signaling in the central amygdala is recruited during binge-like ethanol consumption in C57BL/6J mice. J. Neurosci. 2012, 32(10):3405-3413.
59. Cozzoli D.K., et al. Protein kinase C. epsilon activity in the nucleus accumbens and central nucleus of the amygdala mediates binge alcohol consumption. Biol. Psychiatry 2015.
60. Liu J., et al. Binge alcohol drinking is associated with GABAA alpha2-regulated Toll-like receptor 4 (TLR4) expression in the central amygdala. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(11):4465-4470.
61. Gilpin N.W., Roberto M. Neuropeptide modulation of central amygdala neuroplasticity is a key mediator of alcohol dependence. Neurosci. Biobehav. Rev. 2012, 36(2):873-888.
62. Moller C., et al. Decreased experimental anxiety and voluntary ethanol consumption in rats following central but not basolateral amygdala lesions. Brain Res. 1997, 760(1-2):94-101.
63. Obara I., et al. Differential effects of chronic ethanol consumption and withdrawal on homer/glutamate receptor expression in subregions of the accumbens and amygdala of P rats. Alcohol. Clin. Exp. Res. 2009, 33(11):1924-1934.
64. Roberto M., Gilpin N.W., Siggins G.R. The central amygdala and alcohol: role of gamma-aminobutyric acid, glutamate, and neuropeptides. Cold Spring Harb. Perspect. Med. 2012, 2(12):a012195.
65. Dong H.W., Petrovich G.D., Swanson L.W. Topography of projections from amygdala to bed nuclei of the stria terminalis. Brain Res. Rev. 2001, 38(12):192-246.
66. Funk D., Li Z., Le A.D. Effects of environmental and pharmacological stressors on c-fos and corticotropin-releasing factor mRNA in rat brain: relationship to the reinstatement of alcohol seeking. Neuroscience 2006, 138(1):235-243.
67. Kovacs K.J. C-fos as a transcription factor: a stressful (re) view from a functional map. Neurochem. Int. 1998, 33(4):287-297.
68. Olive M.F., et al. Elevated extracellular crf levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacol. Biochem. Behav. 2002, 72(1-2):213-220.
69. Kash T.L. The role of biogenic amine signaling in the bed nucleus of the stria terminals in alcohol abuse. Alcohol 2012, 46(4):303-308.
70. Silberman Y., Winder D.G. Emerging role for corticotropin releasing factor signaling in the bed nucleus of the stria terminalis at the intersection of stress and reward. Front Psychiatry 2013, 4:42.
71. Ito R., Hayen A. Opposing roles of nucleus accumbens core and shell dopamine in the modulation of limbic information processing. J. Neurosci. 2011, 31(16):6001-6007.
72. Chaudhri N., et al. Separable roles of the nucleus accumbens core and shell in context- and cue-induced alcohol-seeking. Neuropsychopharmacology 2010, 35(3):783-791.
73. Lum E.N., et al. MGluR1 within the nucleus accumbens regulates alcohol intake in mice under limited-access conditions. Neuropharmacology 2014, 79:679-687.
74. Szumlinski K.K., et al. Accumbens Homer2 overexpression facilitates alcohol-induced neuroplasticity in C57BL/6J mice. Neuropsychopharmacology 2008, 33(6):1365-1378.
75. Karkhanis A.N., et al. Chronic intermittent ethanol exposure reduces presynaptic dopamine neurotransmission in the mouse nucleus accumbens. Drug Alcohol Depend. 2015.
76. Cardinal R.N., et al. The contribution of the amygdala, nucleus accumbens, and prefrontal cortex to emotion and motivated behaviour. Int. Cong. Ser. 2003, 1250:347-370.
77. Silberman Y., Matthews R.T., Winder D.G. A corticotropin releasing factor pathway for ethanol regulation of the ventral tegmental area in the bed nucleus of the stria terminalis. J. Neurosci. 2013, 33(3):950-960.
78. Kiefer F., Wiedemann K. Neuroendocrine pathways of addictive behaviour. Addict. Biol. 2004, 9(3-4):205-212.
79. Spanagel R., Noori H.R., Heilig M. Stress and alcohol interactions: animal studies and clinical significance. Trends Neurosci. 2014, 37(4):219-227.
80. Sarnyai Z., Shaham Y., Heinrichs S.C. The role of corticotropin-releasing factor in drug addiction. Pharmacol. Rev. 2001, 53(2):209-243.
81. Gilpin N.W. Corticotropin-releasing factor (CRF) and neuropeptide Y (NPY): effects on inhibitory transmission in central amygdala, and anxiety- & alcohol-related behaviors. Alcohol 2012, 46(4):329-337.
82. Valdez G.R., et al. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcohol. Clin. Exp. Res. 2002, 26(10):1494-1501.
83. Huang M.M., et al. Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation to stress-induced sensitization. J. Pharmacol. Exp. Ther. 2010, 332(1):298-307.
84. Rassnick S., et al. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res. 1993, 605(1):25-32.
85. Baldwin H.A., et al. Crf antagonist reverses the anxiogenic response to ethanol withdrawal in the rat. Psychopharmacology (Berl.) 1991, 103(2):227-232.
86. Funk C.K., et al. Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol. Psychiatry 2007, 61(1):78-86.
87. Valdez G.R., Sabino V., Koob G.F. Increased anxiety-like behavior and ethanol self-administration in dependent rats: reversal via corticotropin-releasing factor-2 receptor activation. Alcohol. Clin. Exp. Res. 2004, 28(6):865-872.
88. Smith R.J., Aston-Jones G. Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence. Brain Struct. Funct. 2008, 213(1-2):43-61.
89. Koob G.F. Addiction is a reward deficit and stress surfeit disorder. Front Psychiatry 2013, 4:72.
90. Silberman Y., et al. Neurobiological mechanisms contributing to alcohol-stress-anxiety interactions. Alcohol 2009, 43(7):509-519.
91. Thevos A.K., et al. Symptoms of anxiety in inpatient alcoholics with and without DSM-III-R anxiety diagnoses. Alcohol. Clin. Exp. Res. 1991, 15(1):102-105.